Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SS18L2P1 (Synovial sarcoma translocation gene on chromosome 18-like 2 pseudogene 1) is a human pseudogene related to the SS18L2 protein-coding gene family. Pseudogenes are DNA sequences similar to functional genes but unable to code for functional proteins due to disabling mutations. Although some pseudogenes can contribute to gene regulation via noncoding RNA mechanisms, there is no evidence that SS18L2P1 has any functional role or disease association.
None. No mechanisms of action for drugs, since it is not a therapeutic target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synovial sarcoma translocation gene on chromosome 18-like 2 pseudogene 1 (SS18L2P1).